Alteration in the Immune Microenvironment Based on APC Status in MSS/pMMR Colon Cancer

INTRODUCTION: Immunotherapy is currently the most promising antitumor treatment approach. However, the colon cancer immunotherapy indication dMMR/MSI-H do not cover all colon cancer patients suitable for immunotherapy. We performed transcriptome-wide expression profile analyses of pMMR/MSS colon ade...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Haishan, Cao, Bangwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348928/
https://www.ncbi.nlm.nih.gov/pubmed/35937946
http://dx.doi.org/10.1155/2022/3592990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348928/
https://www.ncbi.nlm.nih.gov/pubmed/35937946
http://dx.doi.org/10.1155/2022/3592990

Ejemplares similares